COSMO Wave 2.3
New questions on rapid test access and use, mask-wearing, and measures to improve indoor ventilation
Impact Canada, Impact & Innovation Unit, Privy Council Office
Key Insights
- Public Health Measures: In Wave 2.3, 41% of respondents indicated that they either have had, or likely have had, COVID-19 at some point. 30% of respondents reported having been tested for COVID-19 in the past month, either using a rapid test or a PCR test. 84% of respondents reported ‘often’ or ‘always’ wearing a face mask when mandatory and 47% when it was not mandatory.
-
Vaccination: 91% of COSMO respondents had at least one dose of a COVID-19 vaccine, which was in line with real world vaccine uptake for the 18+ population. 72% of the COSMO sample had at least 3 doses of a COVID-19 vaccine, which was higher than real world uptake (59%). First, second and third dose uptake have not shifted meaningfully since the beginning of data collection in February 2022. Among unvaccinated respondents (9% of total sample), 94% indicated that they do not intend to be vaccinated, while 5% were unsure. Among respondents with 2 doses of a COVID-19 vaccine (i.e., who had not yet received a booster dose), 23% indicated that they were likely to get a third dose and 72% indicated they were unlikely to get one. This represents a decrease in intentions compared to previous waves of data collection. Among respondents with 3 doses, 78% indicated that they were likely to get a fourth dose if it becomes available and recommended.
- Pediatric Vaccination: 39% of parents intend to vaccinate their 0-4 year olds either as soon as possible (31%) or after some time (8%). Intentions to vaccinate children in this age group have not shifted significantly since data collection began in February 2022. In all three waves of data collection, the portion of parents with children aged 5-11 indicating that their children were unvaccinated remained consistent (42-43%), suggesting that first dose uptake has stalled in this age group. 81% of parents with children aged 12-17 indicated that their children had at least one dose of a COVID-19 vaccine and 27% had three doses. Across the three waves of data collection, first and second dose uptake have not shifted significantly in the 12-17 population, however, the portion of children 12-17 with 3 doses has increased across waves.
- Sources of Information & Trust: In Wave 2.3, the vast majority of respondents indicated a great deal of trust (4-5 out of 5) in healthcare workers (82%) and scientific experts (81%) for information on COVID-19. Trust in the federal government (62%) and provincial/territorial governments (60%) was also high, relative to other sources of information, such as friends/family (32%).There were no significant changes in trust in information sources between Waves 2.1 and 2.3. Of concern, only 25% agreed that the federal government listens to what ordinary people think about COVID-19.
- COVID-19 Knowledge & Misinformation: A minority of respondents indicated that false statements about COVID-19 were ‘very accurate’ or ‘somewhat accurate’, and questioned the accuracy of some true statements. For example, 23% thought it was very or somewhat accurate that “there is little to no evidence that masks help to reduce the spread of COVID-19”. Additionally, a majority (65%) of respondents reported that they are ‘extremely’ or ‘very’ concerned about the spread of mis/disinformation online. Levels of concern were consistent between Waves 2.2 and 2.3.
- Mental Health & Wellbeing: In Wave 2.3, 72% of respondents reported that they were satisfied with their lives as a whole - life satisfaction has been trending upward since Wave 2.1 (65%). In a related question on mental health, 35% of respondents indicated that their overall mental health has declined since the beginning of the pandemic in March 2020 (49% reported a decline in February 2022). Many respondents reported that they had felt stressed (69%), burnt out (50%), angry (53%), and anxious (63%) in the past two weeks.
- Pandemic Outlook & Recovery: A majority (58%) of respondents reported that ‘the worst of the crisis is behind us’ (a slight increase from 51% in Waves 2.1 and 2.2), but many respondents remain unsure (22%). Despite a majority of respondents indicating that the worst of the crisis is behind us, 24% of respondents still anticipate that it will be longer than 6 months before day-to-day life in Canada resembles pre-pandemic times and 27% think life will ‘never’ resemble pre-pandemic times. Economic worries are top of mind for respondents. Respondents have become less worried about the impact of COVID-19 on the economy over time (63% in Wave 2.1 to 46% in Wave 2.3), and more concerned about inflation and cost-of-living increases (77% in Wave 2.1 to 79% in Wave 2.3). Health worries related to the pandemic have declined since data collection began in February. Respondents remain the most worried about increasing divisiveness and/or conflict within society (62%), and the health system being overloaded (52%).
Background
From April 2020 to November 2021, Impact Canada led the implementation of the World Health Organization (WHO) Behavioural Insights (BI) Tool on COVID-19 in the Canadian context. This study - COVID-19 Snapshot Monitoring (COSMO Canada) - was conducted in collaboration with the Public Opinion Research Team at the Privy Council Office and the Public Health Agency of Canada. Insights from COSMO Phase One informed the federal response to COVID-19 and enabled whole-of-government decision making to meet the specific, changing needs of citizens throughout the pandemic.
In February 2022, Impact Canada launched the second phase and will continue to monitor the evolving pandemic response context with a new sample of Canadians and a new Advisory Committee.
Methodology
With a longitudinal design, the study follows 2,000 participants recruited from an online panel over eight waves of data collection. Respondents are a representative mix of Canadian adults aged 18 years and older and results are weighted using 2016 Statistics Canada census data to mirror the population distribution in Canada. For more information on the study methodology, please visit the COSMO Canada pre-registration page .
Considerations
Data Collected: June 1-24, 2022
Sample size: 2,000
When interpreting the COSMO results it is useful to keep in mind the context of the data collection period, which may have influenced the responses of survey participants:
- COVID-19 case numbers were decreasing or stable as we entered the summer months and most public health measures were lifted. However, some areas were reporting increases in some indicators and the overall proportion of BA.4 and BA.5 among sequenced variants was increasing by the end of the data collection period.
- Most Canadians were vaccinated. As of June 19, 2022, approximately 93% of the Canadian population aged 18+ had received at least one dose of a COVID-19 vaccine, 90% had at least two doses, 59% had at least three doses, and 9% had four doses.
- Among children aged 12-17, 88% had at least one dose, 84% had at least two doses, and 18% had three doses. Among children aged 5-11, 56% had at least one dose and 42% had two doses.
- At the time of data collection, no COVID-19 vaccines had been approved for children aged 4 and under in Canada. However, in the US, vaccines were approved for children aged over 6 months on June 18, with media coverage on likely approval beginning earlier that week.
- On June 14 - midway through the data collection period - the Government of Canada announced that it would be removing proof of vaccination requirements for Canadians travelling by plane or rail. As of June 20, the Government also announced that it was suspending mandatory vaccination for federal employees.
- Health Canada’s authorization of the Moderna COVID-19 vaccine in children 6 months to 5 years of age was announced after the data collection period had concluded (July 14, 2022).